GNCC Capital (OTCPK:GNCP) - Stock Price, News & Analysis

GNCP Stock Overview

Through its subsidiary, BioCann Pharma S.A.S., produces and sells cannabis CBD pharmaceutical grade oils. More details

GNCP fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Does not have a meaningful market cap ($174K)

Latest financial reports are more than a year old

GNCC Capital, Inc. Competitors

Ampio Pharmaceuticals

OTCPK:AMPE

US$3.0k

Kid Castle Educational

OTCPK:KDCE

US$357.2k

Veritas Farms

OTCPK:VFRM

US$81.9k

CBD Life Sciences

OTCPK:CBDL

US$1.4m

Price History & Performance

Summary of all time highs, changes and price drops for GNCC Capital
Historical stock prices
Current Share Price	US$0.000001
52 Week High	US$0.0001
52 Week Low	US$0.000001
Beta	0
11 Month Change	0%
3 Month Change	0%
1 Year Change	0%
33 Year Change	-99.00%
5 Year Change	-99.00%
Change since IPO	-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	GNCP	US Pharmaceuticals	US Market
7D	0%	2.6%	0.5%
1Y	0%	13.1%	30.7%

Return vs Industry: GNCP underperformed the US Pharmaceuticals industry which returned 14.2% over the past year.

Return vs Market: GNCP underperformed the US Market which returned 32.3% over the past year.

Price Volatility

Is GNCP's price volatile compared to industry and market?
GNCP volatility
GNCP Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	9.9%
Market Average Movement	6.3%
10% most volatile stocks in US Market	16.3%
10% least volatile stocks in US Market	3.1%

Stable Share Price: Data is not available.

Volatility Over Time: Insufficient data to determine GNCP's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	n/a	Ted Blom	www.gncc-capital.com

GNCC Capital, Inc. through its subsidiary, BioCann Pharma S.A.S., produces and sells cannabis CBD pharmaceutical grade oils. It sells its products through distribution channels in Colombia and throughout Latin America. The company is based in Las Vegas, Nevada.

GNCC Capital, Inc. Fundamentals Summary

How do GNCC Capital's earnings and revenue compare to its market cap?
GNCP fundamental statistics
Market cap	US$174.14k
Earnings (TTM)	-US$1.32m
Revenue (TTM)	n/a

0.0x

P/S Ratio

0.0x

P/E Ratio

Is GNCP overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
GNCP income statement (TTM)
Revenue	US$0
Cost of Revenue	US$0
Gross Profit	US$0
Other Expenses	US$1.32m
Earnings	-US$1.32m

Last Reported Earnings

Sep 30, 2012

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did GNCP perform over the long term?

See historical performance and comparison